Cargando…
High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study
PURPOSE: Skin cancers are the most common human malignancy with increasing incidence. Currently, surgery is standard of care treatment for non-melanoma skin cancers. However, brachytherapy is a growing modality in the management of skin cancers. Therefore, we aimed to assess the outcome of patients...
Autores principales: | Kalaghchi, Bita, Esmati, Ebrahim, Ghalehtaki, Reza, Gomar, Marzieh, Jaberi, Ramin, Gholami, Soraya, Babaloui, Somayyeh, Nabavi, Mansoureh, Sotoudeh, Sarvazad, Khanjani, Nezhat, Kazemian, Ali, Amouzegar-Hashemi, Farnaz, Aghili, Mahdi, Lashkari, Marzieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961526/ https://www.ncbi.nlm.nih.gov/pubmed/29789760 http://dx.doi.org/10.5114/jcb.2018.75596 |
Ejemplares similares
-
Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran
por: Kazemian, Ali, et al.
Publicado: (2017) -
Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer
por: Amouzegar-Hashemi, Farnaz, et al.
Publicado: (2019) -
Complication and response assessment of high-dose-rate endorectal brachytherapy boost in neo-adjuvant chemoradiotherapy of locally advanced rectal cancer with long-term outcomes
por: Saeedian, Arefeh, et al.
Publicado: (2023) -
A comparison between 2D and 3D planning of high-dose-rate vaginal cuff brachytherapy in patients with stage I-II endometrial cancer using cobalt-60
por: Hashemi, Farnaz Amouzegar, et al.
Publicado: (2021) -
High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced esophageal cancer: preliminary results
por: Safaei, Afsaneh Maddah, et al.
Publicado: (2017)